Each year, scientists create an influenza (flu) vaccine that protects against a few specific influenza strains that researchers predict are going to be the most common during that year. Now, a new study shows that scientists may be able to create a ‘universal’ vaccine that can provide broad protection against numerous influenza strains, including those that could cause future pandemics.
The study appears in mBio, the online open-access journal of the American Society for Microbiology.
“The reason researchers change the vaccine every year is that they want to specifically match the vaccine to the particular viruses that are circulating, such as H1N1. If the vaccine is just a little bit different to the target virus, it is not expected to offer much protection,” said principal investigator of the study Jeffery Taubenberger, MD, PhD, Chief of Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID). “What we have done is design a strategy where you don’t have to think about matching the vaccine antigen to the virus at all.”
In the new study, researchers at the NIAID used a virus-like particle vaccine cocktail that expressed a handful of different subtypes of a key surface protein of the influenza virus: hemagglutinin H1, H3, H5 and H7. “There are 16 different hemagglutinin subtypes that circulate in birds and are thought to be the basis for current and future influenza pandemics,” said Dr. Taubenberger. “The hypothesis was that the presentation of these different viral proteins would stimulate the development of cross-protective immunity that would provide broader protection against multiple subtypes.”
The researchers picked the H1 and H3 subtypes because they have been the major cause of human seasonal flu outbreaks since 1918. They chose the H5 and H7 subtypes because they have been the cause of recent bird flu outbreaks and have pandemic potential. This selection also provided a broad representation of hemagglutinins across the phylogenetic tree.
In a series of experiments, the researchers found that 95% of mice vaccinated with the investigational cocktail were protected against a lethal challenge with eight different influenza strains expressing seven different influenza A subtypes, compared to only 5% of mice who received mock vaccinations.
“Almost all of the animals that were vaccinated survived, including mice that were challenged with viruses that expressed hemagglutinin subtypes that were not in the vaccine at all, viruses that expressed H2, H6, H10, and H11,” said Dr. Taubenberger. “What that suggests is that this approach really gives us broad spectrum protection, and could serve as a basis for an effective pre-pandemic vaccine.”
Additional experiments showed that the vaccine was durable, effective for at least 6 months, and that it worked well in older mice. This is important given that elderly people are particularly susceptible to severe disease following influenza infection, and current vaccines are less efficacious in the elderly than in younger people.
“These initial findings are very positive and suggest a promising and practical strategy for developing a vaccine with amazing, broad protection,” said Dr. Taubenberger.
Read more: UNIVERSAL FLU VACCINE IN THE WORKS
The Latest on: Universal Flu Vaccine
via Google News
The Latest on: Universal Flu Vaccine
- Kenya: Battle Against Flu Gets a Boost With Sh1.2 Billion Granton September 5, 2019 at 12:10 am
The world could get a universal vaccine that is effective against all strains of influenza viruses. This is after eight scientists received funding from the Bill & Melinda Gates Foundation to ...
- Battle against flu gets a boost with Sh1.2bn granton September 3, 2019 at 11:03 pm
The world could get a universal vaccine that is effective against all strains of influenza viruses. This is after eight scientists received funding from the Bill & Melinda Gates Foundation to develop ...
- Oregon hospital researching the development of a universal flu vaccineon August 30, 2019 at 2:34 pm
PORTLAND, Ore. (KWCH) - Oregon Health & Science University Hospital is researching the creation of a universal flu vaccine with the help of a grant from the Bill and Melinda Gates Foundation. The ...
- Oregon researchers aiming to make your yearly flu shot a thing of the paston August 30, 2019 at 1:48 am
Last year marked 100 years since the deadliest flu pandemic in history, known as the 1918 influenza pandemic. The centennial spurred the Bill and Melinda Gates Foundation to start the Grand Challenge ...
- Seasonal Influenza Vaccines Market Growth Rate, Manufacturers, Market Dynamics, Market Overviewon August 29, 2019 at 4:40 pm
Also, National Institute of Allergy and Infectious Disease (NIAID) is engaged in developing new strategic plan to develop novel, safe and effective universal influenza vaccine. Various government ...
- OHSU receives grant from Gates Foundation to develop universal flu vaccineon August 29, 2019 at 2:46 pm
Oregon Health & Science University received a grant from the Gates Foundation to develop the Holy Grail of vaccines: a universal flu vaccine. OHSU is one of about six institutions that are splitting ...
- Gates Foundation donates $12M to universal flu vaccine researchon August 29, 2019 at 8:59 am
Up to eight research teams will receive about $12 million in funding to research a universal flu vaccine, thanks to grants from the Bill and Melinda Gates Foundation and the philanthropic organization ...
- With new grants, Gates Foundation takes an early step toward a universal flu vaccineon August 29, 2019 at 1:46 am
Scientific teams from inside and outside the world of influenza research have been awarded funding to try to unlock mysteries that could provide the foundation for a future universal flu vaccine, the ...
- BiondVax Welcomes New Chairman of the Board and Announces Second Quarter 2019 Financial Resultson August 28, 2019 at 4:45 am
Recent events have positioned BiondVax to become a successful manufacturer and marketer of its M-001 universal flu vaccine candidate. In July we closed on a financing of US$20M predominantly ...
- Meet The Synthetic Biology Company Engineering Your Immune Systemon August 27, 2019 at 10:45 pm
It’s taken 30 years of biotech, but synthetic biology can now engineer antibodies in the lab faster than the body can do it, with potential cures for everything from snake bites to a universal flu ...
via Bing News